BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 31422942)

  • 1. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma.
    Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L
    Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
    Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
    Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
    Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
    BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
    Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
    Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
    Xu D; Xu Y; Lv Y; Wu F; Liu Y; Zhu M; Chen D; Bai B
    Biomed Res Int; 2020; 2020():2137319. PubMed ID: 32309427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.
    Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X
    Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
    Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL
    Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co‑expression analysis.
    Yuan L; Chen L; Qian K; Wang G; Lu M; Qian G; Cao X; Jiang W; Xiao Y; Wang X
    Oncol Rep; 2018 Feb; 39(2):525-536. PubMed ID: 29207195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
    Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
    Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
    Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
    PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis.
    Zhai W; Lu H; Dong S; Fang J; Yu Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):853-863. PubMed ID: 32556097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis.
    Wang L; Lin Y; Yuan Y; Liu F; Sun K
    Biochem Genet; 2021 Oct; 59(5):1278-1294. PubMed ID: 33786672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC).
    Du GW; Yan X; Chen Z; Zhang RJ; Tuoheti K; Bai XJ; Wu HH; Liu TZ
    Aging (Albany NY); 2020 May; 12(9):8484-8505. PubMed ID: 32406866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Prognostic Related Hub Genes in Clear-Cell Renal Cell Carcinoma
    Jiang P; Sun TT; Chen CW; Huang RS; Zhong ZM; Lou XJ; Liu G; Wang L; Zuo RH
    Chin Med Sci J; 2021 Jun; 36(2):127-134. PubMed ID: 34231461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
    Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ
    Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.
    Xu T; Ruan H; Gao S; Liu J; Liu Y; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Shi J; Liang H; Yang H; Chen K; Zhang X
    Aging (Albany NY); 2020 Jan; 12(2):1808-1827. PubMed ID: 32003757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.